Four novel conformationally restricted (?)-muricatacin analogues bearing a
methoxy group at the C-5 position, with an alkoxymethyl group ?s the C-7
side chain, have been synthesised and their in vitro antiproliferative
activity was evaluated against a panel of seven human tumour cell lines, as
well as a single normal cell line. All analogues (9-12) showed diverse
antiproliferative effects against all tested human malignant cell lines, but
were devoid of any significant cytotoxicity towards the normal foetal lung
fibroblasts (MRC-5). A SAR study reveals that the introduction of THF ring,
exchange of C-8 methylene group in the side chain of muricatacin analogues
with the O-8 ether functionality, as well as the length of side chain may be
beneficial for the antiproliferative effects of these lactones. All novel
analogues were more potent than lead compound, (?)-muricatacin, against
HL-60 cell line.